113 related articles for article (PubMed ID: 8299382)
1. Suppression of induced inflammation in man.
Kerscher MJ
Curr Probl Dermatol; 1993; 21():97-106. PubMed ID: 8299382
[No Abstract] [Full Text] [Related]
2. The UV erythema test as a model to investigate the anti-inflammatory potency of topical preparations--reevaluation and optimization of the method.
Jocher A; Kessler S; Hornstein S; Schulte Mönting J; Schempp CM
Skin Pharmacol Physiol; 2005; 18(5):234-40. PubMed ID: 16015022
[TBL] [Abstract][Full Text] [Related]
3. Topical glucocorticoids and thinning of normal skin as to be assessed by ultrasound.
Korting HC
Curr Probl Dermatol; 1993; 21():114-21. PubMed ID: 8299364
[No Abstract] [Full Text] [Related]
4. Side effects of topical glucocorticoids.
Mills CM; Marks R
Curr Probl Dermatol; 1993; 21():122-31. PubMed ID: 8299365
[No Abstract] [Full Text] [Related]
5. Investigation of the anti-inflammatory potential of Aloe vera gel (97.5%) in the ultraviolet erythema test.
Reuter J; Jocher A; Stump J; Grossjohann B; Franke G; Schempp CM
Skin Pharmacol Physiol; 2008; 21(2):106-10. PubMed ID: 18253066
[TBL] [Abstract][Full Text] [Related]
6. Early detection of glucocorticoid-specific epidermal alterations using skin surface microscopy.
Schulz H; Nietsch KH; Höhler T
Curr Probl Dermatol; 1993; 21():132-9. PubMed ID: 8299366
[No Abstract] [Full Text] [Related]
7. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
Schäfer-Korting M; Korting HC; Kerscher MJ; Lenhard S
Clin Pharmacol Ther; 1993 Oct; 54(4):448-56. PubMed ID: 8222488
[TBL] [Abstract][Full Text] [Related]
8. Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound.
Kerscher MJ; Korting HC
Acta Derm Venereol; 1992; 72(3):214-6. PubMed ID: 1357864
[TBL] [Abstract][Full Text] [Related]
9. Intensity and area increase of UVB-induced erythema: two variables used for studies of the influence of topically applied drugs.
Juhlin L; Shroot B
Acta Derm Venereol; 1993 Aug; 73(4):273-5. PubMed ID: 7904100
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial comparing hydrocortisone 17-butyrate to betamethasone 17-valerate in a series of patients with eczematous skin diseases.
Thormann J; Brodthagen H
Dermatologica; 1976; 152 Suppl 1():209-14. PubMed ID: 782955
[TBL] [Abstract][Full Text] [Related]
11. Local tolerability of topically applied methylprednisolone aceponate.
Kecskés A; Jahn P; Lange L
J Am Acad Dermatol; 1993 May; 28(5 Pt 1):786-8. PubMed ID: 8496430
[No Abstract] [Full Text] [Related]
12. Influence of glucocorticoid substances and the vehicle on skin irritancy: determination by profilometry.
Korting HC
Curr Probl Dermatol; 1993; 21():140-6. PubMed ID: 8299367
[No Abstract] [Full Text] [Related]
13. Vasoconstrictor and the anti-inflammatory effects of 7 corticosteroids.
Crijns MB; Nater JP; van Oostveen F; van der Valk PG
Contact Dermatitis; 1984 Aug; 11(2):108-11. PubMed ID: 6488765
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the bioactivity of mometasone furoate 0.1% fatty cream, betamethasone dipropionate 0.05% cream and betamethasone valerate 0.1% cream in humans. Inhibition of UV-B-induced inflammation monitored by laser Doppler blood flowmetry.
Bjerring P
Skin Pharmacol; 1993; 6(3):187-92. PubMed ID: 8274288
[TBL] [Abstract][Full Text] [Related]
15. UVB erythema inhibited by topically applied substances.
Väänänen A; Hannuksela M
Acta Derm Venereol; 1989; 69(1):12-7. PubMed ID: 2563602
[TBL] [Abstract][Full Text] [Related]
16. Suppression of ultraviolet erythema by topical corticosteroids.
Sukanto H; Nater JP; Bleumink E
Dermatologica; 1980; 161(2):84-8. PubMed ID: 7398988
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of hydrocortisone valerate 0.2% ointment.
Sefton J; Loder JS; Kyriakopoulos AA
Clin Ther; 1984; 6(3):282-93. PubMed ID: 6373007
[TBL] [Abstract][Full Text] [Related]
18. Betamethasone valerate in corticosteroid-dependent asthmatics. The integrity of the hypothalamic pituitary adrenal axis.
Roscoe P; Choo-Kang YF; Horne NW
Br J Dis Chest; 1975 Oct; 69(0):240-6. PubMed ID: 1106745
[TBL] [Abstract][Full Text] [Related]
19. A double-blind comparison of 0.25% and 0.05% desoxymethasone, 0.1% betamethasone valerate and 1% hydrocortisone creams in the treatment of eczema.
Ashton RE; Catterall M; Morley N; Fairris G; Joseph DN
J Int Med Res; 1987; 15(3):160-6. PubMed ID: 3301455
[TBL] [Abstract][Full Text] [Related]
20. Influence of the base on the results of clinical trials with topical corticosteroids.
Vollum DI; Sparkes CG
Dermatologica; 1979; 158(4):293-8. PubMed ID: 372027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
